Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “VITAL CAPACITY”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 505 records · Page 28Linked to original sources

[Comparative assessment of the theoretical values of vital capacity (VC) considered normal by various authors].

Values of VC for "theoretical subjects" of comparable sexes, age, height were found in tables and normograms according to Baldwin, Berglund, Kory, Nikodemowicz and Morris. For each series of values, mean, standard deviation, minimal, maximal, and median values were calculated. A differential test was performed to assess significance. Statistically significant differences were found. The highest values were expressed by Morris lowest by Berglund. It seems that one should rather use real values instead of predicted and new reference values are needed due to a change of height-age relation during the past 20 years.

Adult↗

133Xe radiospirometry in prediction of ventilatory function and vital capacity after pneumonectomy in patients with an endobronchial tumour.

The ventilatory parameters FEV1 and VC were predicted after pneumonectomy in 18 patients operated on because of an endobronchial carcinoma. Preoperative dynamic spirometry and radiospirometrically determined regional ventilation, perfusion and VC were used in the prediction. In the whole patient material the predicted postoperative FEV1 and VC correlated significantly with the measured postoperative values; the correlation coefficients of the estimates based on preoperative regional perfusion (rFEV1 = 0.760, rVC = 0.707) differed, however, somewhat from those of the estimates based on regional ventilation (rFEV1 = 0.736, rVC = 0.767). The use of regional VC did not improve the accuracy of estimation. The mean predicted values of FEV1 were 0.35-0.46/l and those of VC were 0.23-0.44/l smaller than the values actually measured 2-12 months after operation, probably owing to dilatation of the remaining lung.

Aged↗

[Value of 25-75 percent maximum expiratory flow as compared with vital capacity (ratio of MEF 25-75 to VC) in the detection of ventilatory disorders of the small air passages].

The author has investigated the feasibility of DME 25--75/C.V. as a test for the detection of ventilatory disturbances of the small aerial pathways, by comparing the results with those of other tests considered to be very sensitive, such as Vmax 50% and 25% of C.V., Vmax 50% and 25% of C.V. of an air curve and that of a He-O2 mixture (80%--20%), and the isoflow volume. The study was carried out in 90 subjects, divided in two groups in relation to the values obtained by the DME 25--75/C.V., as follows : 44 subjects with bronchial obstruction and 46 subjects showing functional signs of obstruction of the small aerial pathways. The results have indicated that the two populations classified according to this criterium are statistically different also with regard to other tests applied, indicating the feasibility of the test under study, which, compared to other tests, has the advantage of higher sensitivity in relation to the simplicity of the device.

Airway Obstruction↗

Forced vital capacity and maximal respiratory pressures in patients with mild and moderate scoliosis.

Lung function and maximal respiratory pressures of 24 adolescent females with mild-to-moderate idiopathic scoliosis (spinal curvature 10-60 degrees) were determined and compared with 38 age- and sex-matched controls. Twelve patients with moderate scoliosis (Cobb angle 35-60 degrees) had significantly reduced mean values for FVC (% predicted) and maximal inspiratory pressure (MIP), as compared to the controls. Twelve patients with mild scoliosis (Cobb angle less than 35 degrees) had normal mean values for FVC and maximal respiratory pressures, but five individual patients had FVC values less than 80% predicted. All but one of the patients with mild scoliosis had normal MIP values. FVC (% predicted) was significantly correlated with the degree of spinal curvature (r = -0.466; P less than 0.05) but was not related to MIP. These results indicate that reduced FVC values do occur in patients with mild-to-moderate idiopathic scoliosis and suggest that these low FVC values can be attributed to the rib cage deformity rather than to an inability to generate adequate inspiratory pressures.

Adolescent↗

[Vital capacity and peak expiratory flow rates in a North-African population aged 60 years and over: influence of anthropometric data and parity].

INTRODUCTION: The aims of this study were to calculate predictive equations for respiratory variables (FVC, FEV1, FEF25%-75%, and PEFR) in elderly north-African people and to study the effect of parity on the respiratory function. METHODS: FVC and forced expiratory flows were measured in a "healthy" sample of 186 subjects aged 60 years and over (66% women). The measurements were made in health centres using portable spirometers. Predictive equations were determined by the technique of multiple linear regression using standing height and age as independent variables. The effect of parity on ventilatory function was studied by comparing two groups defined by a parity greater or less than 4. RESULTS: The respiratory variables measured in this elderly north-african population were significantly different from those established references ranges. CONCLUSIONS: High parity is associated with a significant reduction in peak flow rate.

Africa, Northern↗

Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barré syndrome.

In Guillain-Barré syndrome (GBS), respiratory failure is a life-threatening complication, and its occurrence may be difficult to predict. We studied prospectively 10 patients with GBS by serial measurements of pulmonary function and arterial blood gases from the the time they were admitted to hospital. Five patients developed respiratory failure and had to be intubated, whereas the other five developed no ventilatory impairment. VC measurements were very useful in predicting respiratory failure several days before intubation. In patients who were eventually intubated, VC decreased during the 48 h preceding the occurrence of respiratory failure and intubation, which was required when VC was 15.2 +/- 3.7 ml/kg body weight (BW). In nonintubated patients, VC was stable and greater than 40 ml/kg BW. In addition, VC measurements allowed us to determine the beginning of the weaning procedure (no weaning trial could be performed successfully when VC was less than 7 ml/kg BW), to rationally follow its course, and to choose the time for extubation, i.e., when VC was greater than 15 ml/kg BW.

Carbon Dioxide↗

Respirator triggering of electron beam computed tomography (EBCT): research on vital capacities.

In this project we evaluate the dynamic changes during expiration at different levels of positive-end-expiratory pressure (PEEP) in ventilated patients. We wanted to discriminate between normal lung function and acute respiratory distress syndrome (ARDS). After approval by the local Ethic Committee we studied two ventilated patients: (one with normal lung function and one with ARDS) We used the 50 ms scan mode of the EBCT. The beam was positioned 1 cm above the diaphragm while the table position remained unchanged. We developed an electronic trigger that utilizes the respirator's synchronizing signal to start the EBCT at the onset of expiration. During controlled mechanical expiration at two levels of PEEP (0 and 15 cm H2O), pulmonary aeration was rated as: well-aerated (-900HU to -500HU), poorly aerated (-500HU to -100HU) and non-aerated (-100HU to +100HU). Pathological and normal lung functions showed different dynamic changes. The different PEEP levels resulted in a significant change of pulmonary aeration in the same patient. Although we studied only two patients, respiratory triggered EBCT may be accurate in discriminating pathological changes due to the abnormal lung function in a mechanically ventilated patient.

Adult↗

Frequency spectra of flow and volume events for forced vital capacity.

We determined the frequency content of forced expiratory flow-time (FT) and volume-time (VT) curves by a fast Fourier transform to determine the dynamic responses required of devices to reproduce these curves. We analyzed 304 FT and VT curves from 15 normal (N) subjects (ages 8-34 yr), 15 cystic fibrosis (CF) patients (ages 7-36 yr), and 9 smokers (S, ages 20-63 yr). The highest frequency (HF) with significant amplitude content, defined as the highest frequency with 5% or more amplitude of the fundamental, for FT curves in N (mean +/- SD, 5.06 +/- 0.7 Hz) was significantly (P less than 0.05) lower than in CF (6.43 +/- 0.9 Hz) and S (6.49 +/- 1.8 Hz). These differences were due predominantly to flow transients at high lung volumes in CF and S. No significant differences in HF of VT curves were noted among N (3.0 +/- 1.4 Hz), CF (2.9 +/- 1.4 Hz), and S (1.7 +/- 1.5 Hz). All subjects had HF for FT of 12 Hz or less and for VT of 6 Hz or less. For spirometric recordings our results suggest that the amplitude response of flow- and volume-measuring devices should be flat (+/- 5%) up to 12 Hz for flow signals and up to 6 Hz for volume signals.

Adult↗

Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.

A total of 2,880 maximum expiratory flow-volume curves were performed in a controlled double-blind cross-over examination designed to evaluate the bronchodilating effects of two different nebulized doses of salbutamol (1.75 and 0.875 mg) and ipratropium bromide (0.175 and 0.0875 mg) inhaled by 8 normal, 8 asthmatic, and 8 bronchitic subjects. FEV1, FVC, and flows at 50% FVC and at three fixed volumes below TLC have been measured over a period of 6 h on the maximum expiratory flow-volume curve. In the normal subjects, salbutamol seems to have a smaller bronchodilating effect than ipratropium bromide both at high and low lung volumes. After salbutamol the average initial FEV1 increased from 4.0 to 4.3 liters, whereas after ipratropium bromide it increased to 4.4 liters. In our asthmatic patients the initial response to salbutamol was much larger than to ipratropium bromide. After salbutamol FEV1 increased from 1.8 to 2.7 liters in 60 min, whereas after ipratropium bromide it increased to 2.4 liters in 120 min. In our bronchitic patients the difference between the two drugs seems to be very small. After both drugs FEV1 increased from 1.6 to 2.1 liters. The choice of drug for treatment of the condition would then depend on how well the individual patients tolerate the two drugs.

Adult↗

Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. The Cardiovascular Health Study.

The Cardiovascular Health Study provided the opportunity to determine the association of subclinical and clinical cardiovascular disease with pulmonary function in a population sample of elderly adults. Included were 2,955 women and 2,246 men over age 64 years who were recruited for this observational study from four communities and completed extensive examinations that included spirometry, echocardiograms, and blood pressure. Current smokers, past smokers with >20 pack-years of smoking, and persons with a history of asthma, chronic bronchitis, or emphysema were excluded from this analysis, leaving 2,784 (55%) of the cohort. Systolic hypertension or coronary artery disease was associated with 40- to 100-mL decrements in FEV1, and 50- to 150-mL decrements in FVC, while a history of congestive heart failure was associated with 200 to 300 mL lower FEV1 and FVC values (p < 0.0001), after correcting for age, height, and waist size. Higher left ventricular (LV) mass was also significantly associated with a decrease in FEV1 and FVC in multivariate models. This relationship was strongest with the end-diastolic LV posterior wall thickness component of LV mass. In summary, FEV1 and FVC are reduced in elderly persons with hypertension, ischemic heart disease, higher disease, higher LV mass, and congestive heart failure, though the magnitude of these associations is relatively small unless heart failure supervenes. Substantial decrements in percent predicted FEV1 and FVC should not be attributed to the presence of uncomplicated ischemic heart disease or hypertension alone.

Age Factors↗

Customer service, access and capacity: vital signs for developing a marketing plan.

Marketing plans that do not include an analysis of customer service, access and capacity issues are incomplete documents. Unresolved customer service, access and capacity issues can undermine an otherwise well-designed marketing plan. The medical and administrative leadership of the group practice or clinical department must work together to identify customer service, access and capacity issues which are affecting the practice's ability to respond to the needs of the marketplace. Someone with marketing expertise can provide valuable input to this process. The resulting solutions need to be developed which are realistic and in keeping with the general marketing direction of the practice.

Appointments and Schedules↗

Prevalence and features of advanced asbestosis (ILO profusion scores above 2/2). International Labour Office.

In this study, the author addressed the following question: Do workers with advanced asbestosis have a restrictive pulmonary physiology, and, alternately, do those who have restrictive physiological tests have advanced asbestosis? One group was identified by obvious radiographic measurements, and the other group was defined via physiologic measurements. Total lung capacity, vital capacity, and flows were measured in 12,856 men exposed to asbestos, of whom 3,445 had radiographic signs of asbestosis, as defined by the International Labour Office criteria. Radiographically advanced asbestosis-International Labour Office criteria profusion greater than 2/2 was present in 85 (2.5%) of men. An additional 52 men had physiologically restrictive disease. The author, who compared pulmonary flows and volumes of these two groups, used mean percentage predicted, adjusted for height, age, and duration of cigarette smoking. Men with radiographically advanced asbestosis had normal total lung capacity (i.e., 105.5% predicted), reduced forced vital capacities (i.e., 82.7% predicted), air trapping (i.e., residual volume/total lung capacity increased to 54.4%), and reduced flows (i.e., forced expiratory flow [FEF25-75] = 60.6% predicted, forced expiratory volume in 1 s = 78.0% predicted, and forced expiratory volume in 1 s/forced vital capacity = 65.5%). In contrast, men selected from the same exposed population for restrictive disease (i.e., reduced total lung capacity [72.6% predicted] and forced vital capacity [61.5% predicted]) also had airflow obstruction (i.e., forced expiratory volume in 1 s/forced vital capacity of 74.5% predicted) and air trapping (i.e., residual volume/total lung capacity of 46.7%). Only half of these men had asbestosis--and it was of minimal severity. In summary, advanced asbestosis was characterized by airway obstruction and air trapping, both of which reduced vital capacity but not total lung capacity; therefore, it was not a restrictive disease. In contrast, restrictive disease was rare and was associated with minimal asbestosis.

Aged↗

Intrapleural administration of 0.5% plain bupivacaine compared to 0.5% epinephrine: a hemodynamic and ventilatory study.

The ventilatory and hemodynamic effects of 20 ml 0.5% intrapleural bupivacaine with and without 5 micrograms/ml epinephrine were studied. Ten patients scheduled for intrapleural block in the treatment of chronic visceral pain had a left-sided intrapleural catheter inserted. In a double-blind, crossover design they received 20 ml 0.5% bupivacaine with and without 5 micrograms/ml epinephrine. Forced vital capacity, vital capacity, and forced expiratory volume in one second were measured before and 30 minutes after the injection. Mean blood pressure, heart rate, and cardiac output were recorded before the injection and at five-minute intervals for 30 minutes. Vital capacity, forced vital capacity, and forced expiratory volume in one second were unchanged in both groups. There were no differences in any of the pulmonary function tests between the groups. When data from both groups are pooled, vital capacity shows a decrease of 7% (p less than 0.05). No changes in heart rate or mean blood pressure were seen in either group. Bupivacaine without epinephrine did not affect the cardiac output, whereas bupivacaine with epinephrine resulted in a rise in cardiac output of 15% at 15 and 20 minutes after the injection. We did not find any major effects of intrapleural injection of 20 ml 0.5% bupivacaine with and without 5 micrograms/ml epinephrine on ventilatory capacity or cardiovascular function in patients treated for chronic visceral pain.

Adult↗